Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
May 2, 2007

Artemis and Taconic Acquire Kinase-Related Discovery IP from CGI

  •  Taconic Farms and Artemis Pharmaceuticals have jointly acquired the worldwide rights to the ASKA technology from CGI Pharmaceuticals. This approach to in vivo kinase-related drug discovery is based on the replacement of a normal kinase with a selectively modified kinase or ASKA (Analogue Sensitive Kinase Allele) in genetically modified mice.

    Under the terms of the transaction, Artemis and Taconic are assigned the entire portfolio of ASKA IP rights as well as know-how, trade secrets, and materials developed by CGI. Included are the rights to patents based on the chemistry and molecular biology work of Dr. Kevan Shokat, Ph.D., inventor of the ASKA technology.

    Artemis and Taconic will generate, market, and distribute ASKA transgenic mouse models in which a fully functional ASKA replaces the normal kinase gene.



Be sure to take the GEN Poll

CRISPR Patent Controversy

Do you think recently released email from a former Broad Institute scientist to Jennifer Doudna will expedite a final legal decision on who owns the CRISPR patent?

More »